Titan Pharmaceuticals
TTNP
#11024
Rank
NZ$10.93 M
Marketcap
NZ$8.22
Share price
-3.76%
Change (1 day)
16.89%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$8.4 Million, an increase over its 2023 earnings that were of -NZ$9.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-43.68%
2024 -NZ$8.4 Million-15.5%
2023 -NZ$9.94 Million-45.43%
2022 -NZ$18.21 Million16.29%
2021 -NZ$15.66 Million-907.36%
2020 NZ$1.93 M-106.6%
2019 -NZ$29.36 Million82.4%
2018 -NZ$16.1 Million-36.93%
2017 -NZ$25.52 Million-378.62%
2016 NZ$9.15 M-145.53%
2015 -NZ$20.12 Million369.37%
2014 -NZ$4.29 Million-125.9%
2013 NZ$16.54 M-177.74%
2012 -NZ$21.29 Million13.59%
2011 -NZ$18.74 Million74.37%
2010 -NZ$10.75 Million3.61%
2009 -NZ$10.38 Million
2007 -NZ$32.88 Million12.08%
2006 -NZ$29.34 Million-28.65%
2005 -NZ$41.12 Million-10.03%
2004 -NZ$45.7 Million-6.08%
2003 -NZ$48.66 Million-14.76%
2002 -NZ$57.09 Million32.52%
2001 -NZ$43.08 Million27.55%
2000 -NZ$33.78 Million62.5%
1999 -NZ$20.79 Million4.04%
1998 -NZ$19.98 Million49.33%
1997 -NZ$13.38 Million-27.88%
1996 -NZ$18.55 Million13.04%
1995 -NZ$16.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.39 B-667,515.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$22.55 B-450,830.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.32 Billion 6,242.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$54.71 M-1,193.69%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.17 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA